OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: The Scripps Research Institute

3 Projects | 2 Researchers | $400,000 Invested

2014

The Scripps Research Institute

Matthew Disney, PhD

Lead optimization and pre-clinical testing of small molecules that modulate toxicity of cFTD/ALS"

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Other
  • Status: Closed

2014

The Scripps Research Institute

Sathyanarayanan Puthanveettil, PhD

Small molecule modulators of kinesin motility in mammalian brain

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2011

The Scripps Research Institute

Sathyanarayanan Puthanveettil, PhD

Small molecule screen for modulators of kinesin function in mammalian brain

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed